Patents by Inventor Vinod Parikh

Vinod Parikh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20100035873
    Abstract: The invention relates to derivatives of a compound of formula I: wherein R1 to R7 and X1 to X6 are as defined herein. The invention relates to the uses thereof for treating diseases, conditions and/or disorders mediated by kappa opioid receptors (KORs). Specifically, the compounds are selective antagonists of KORs and are highly selective to KORs relative to mu and delta opioid receptors.
    Type: Application
    Filed: June 23, 2009
    Publication date: February 11, 2010
    Inventors: Patrick Verhoest, Matthew Merrill Hayward, Vinod Parikh, Stanton Furst McHardy, Stafford McLean
  • Patent number: 7009051
    Abstract: The present invention relates to compounds of the formula I wherein R1, R2, R3, X and Y are defined as in the specification. Those compounds are 5HT7 partial agonists and are useful in the treatment of several disorders of the central nervous system.
    Type: Grant
    Filed: July 10, 2003
    Date of Patent: March 7, 2006
    Assignee: Pfizer Inc
    Inventors: Willard M. Welch, Vinod Parikh
  • Publication number: 20050256164
    Abstract: The invention is to a compound exhibiting neurokinin inhibitory properties, a pharmaceutical composition comprising same and a method of treatment for neurokinin-mediated conditions.
    Type: Application
    Filed: May 6, 2005
    Publication date: November 17, 2005
    Inventors: Brian O'Neill, Vinod Parikh, Willard Welch
  • Publication number: 20040014769
    Abstract: The present invention relates to compounds of the formula I 1
    Type: Application
    Filed: July 10, 2003
    Publication date: January 22, 2004
    Applicant: Pfizer Inc.
    Inventors: Willard M. Welch, Vinod Parikh
  • Publication number: 20030008880
    Abstract: The present invention relates to compounds of the formula I 1
    Type: Application
    Filed: February 13, 2002
    Publication date: January 9, 2003
    Applicant: Pfizer Inc.
    Inventors: Willard M Welch, Vinod Parikh
  • Patent number: 6333361
    Abstract: Pharmaceutical compositions of 4-(5-cyclopentyloxycarbonylamino-1-methylindol-3-ylmethyl)-3-methoxy-N-o-tolylsulfonylbenzamide and a gelling agent, in particular hydroxypropylmethylcellulose, are described for treating asthma and related diseases. Processes for the preparation of the compositions are described.
    Type: Grant
    Filed: July 11, 2000
    Date of Patent: December 25, 2001
    Assignee: Zeneca Limited
    Inventors: Susan Jane Corvari, Karen Beth Main, Bharvnish Vinod Parikh
  • Patent number: 5948437
    Abstract: The invention relates to sustained release formulations comprising 11-?4-?2-(2-hydroxyethoxy)ethyl!-1-piperazinyl!dibenzo?b,f! ?1,4!thiazepine or a pharmaceutically acceptable salt thereof, to methods of treating psychotic states and hyperactivity utilizing the sustained release formulations and to a process for preparing the sustained release formulations.
    Type: Grant
    Filed: May 28, 1997
    Date of Patent: September 7, 1999
    Assignee: Zeneca Limited
    Inventors: Bhavnish Vinod Parikh, Robert Joseph Timko, William Joseph Addicks